Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Related Posts
Free Bitcoin cloud mining for beginners 2026: Start mining BTC in minutes with no equipment
Hashbitcoin leads 2026 cloud mining, letting beginners earn Bitcoin safely with AI-powered optimization. In 2026, cloud mining has…
Smarter Web eyes distressed rivals as UK Bitcoin treasury race tightens
Smarter Web, the U.K.’s largest BTC holder, is going on the offensive. CEO Andrew Webley is eyeing distressed…
Are Telegram trading bots really safe? A user’s guide to best practices
Explore the critical security insights and essential safety practices for navigating the risks of Telegram crypto trading bots…